Global Somatostatin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 137

Published Date: 02 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Somatostatin market size was valued at USD 346.3 million in 2023 and is forecast to a readjusted size of USD 715 million by 2030 with a CAGR of 10.9% during review period.

Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.

Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%.

China is the largest market, followed by Europe and India.

The Global Info Research report includes an overview of the development of the Somatostatin industry chain, the market status of Hormonal Disorder (0.25mg/pcs, 0.75mg/pcs), Oncology (0.25mg/pcs, 0.75mg/pcs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Somatostatin.

Regionally, the report analyzes the Somatostatin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Somatostatin market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Somatostatin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Somatostatin industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., 0.25mg/pcs, 0.75mg/pcs).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Somatostatin market.

Regional Analysis: The report involves examining the Somatostatin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Somatostatin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Somatostatin:
Company Analysis: Report covers individual Somatostatin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Somatostatin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hormonal Disorder, Oncology).

Technology Analysis: Report covers specific technologies relevant to Somatostatin. It assesses the current state, advancements, and potential future developments in Somatostatin areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Somatostatin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Somatostatin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
0.25mg/pcs
0.75mg/pcs
3mg/pcs

Market segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others

Major players covered
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin from 2019 to 2024.
Chapter 3, the Somatostatin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Somatostatin.
Chapter 14 and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Somatostatin
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Somatostatin Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 0.25mg/pcs
        1.3.3 0.75mg/pcs
        1.3.4 3mg/pcs
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Somatostatin Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hormonal Disorder
        1.4.3 Oncology
        1.4.4 Metabolic Disorder
        1.4.5 Others
    1.5 Global Somatostatin Market Size & Forecast
        1.5.1 Global Somatostatin Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Somatostatin Sales Quantity (2019-2030)
        1.5.3 Global Somatostatin Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Merck (Schweiz) AG
        2.1.1 Merck (Schweiz) AG Details
        2.1.2 Merck (Schweiz) AG Major Business
        2.1.3 Merck (Schweiz) AG Somatostatin Product and Services
        2.1.4 Merck (Schweiz) AG Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck (Schweiz) AG Recent Developments/Updates
    2.2 SANOFI-AVENTIS FRANCE
        2.2.1 SANOFI-AVENTIS FRANCE Details
        2.2.2 SANOFI-AVENTIS FRANCE Major Business
        2.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Services
        2.2.4 SANOFI-AVENTIS FRANCE Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 SANOFI-AVENTIS FRANCE Recent Developments/Updates
    2.3 Lyomark Pharma GmbH
        2.3.1 Lyomark Pharma GmbH Details
        2.3.2 Lyomark Pharma GmbH Major Business
        2.3.3 Lyomark Pharma GmbH Somatostatin Product and Services
        2.3.4 Lyomark Pharma GmbH Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Lyomark Pharma GmbH Recent Developments/Updates
    2.4 ALFA WASSERMANN S.p.A.
        2.4.1 ALFA WASSERMANN S.p.A. Details
        2.4.2 ALFA WASSERMANN S.p.A. Major Business
        2.4.3 ALFA WASSERMANN S.p.A. Somatostatin Product and Services
        2.4.4 ALFA WASSERMANN S.p.A. Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 ALFA WASSERMANN S.p.A. Recent Developments/Updates
    2.5 Polypeptide Laboratories, Inc
        2.5.1 Polypeptide Laboratories, Inc Details
        2.5.2 Polypeptide Laboratories, Inc Major Business
        2.5.3 Polypeptide Laboratories, Inc Somatostatin Product and Services
        2.5.4 Polypeptide Laboratories, Inc Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Polypeptide Laboratories, Inc Recent Developments/Updates
    2.6 SAMARTH
        2.6.1 SAMARTH Details
        2.6.2 SAMARTH Major Business
        2.6.3 SAMARTH Somatostatin Product and Services
        2.6.4 SAMARTH Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 SAMARTH Recent Developments/Updates
    2.7 UBPL
        2.7.1 UBPL Details
        2.7.2 UBPL Major Business
        2.7.3 UBPL Somatostatin Product and Services
        2.7.4 UBPL Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 UBPL Recent Developments/Updates
    2.8 HYBIO
        2.8.1 HYBIO Details
        2.8.2 HYBIO Major Business
        2.8.3 HYBIO Somatostatin Product and Services
        2.8.4 HYBIO Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 HYBIO Recent Developments/Updates
    2.9 TianTaiShan
        2.9.1 TianTaiShan Details
        2.9.2 TianTaiShan Major Business
        2.9.3 TianTaiShan Somatostatin Product and Services
        2.9.4 TianTaiShan Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 TianTaiShan Recent Developments/Updates
    2.10 Yangtze River
        2.10.1 Yangtze River Details
        2.10.2 Yangtze River Major Business
        2.10.3 Yangtze River Somatostatin Product and Services
        2.10.4 Yangtze River Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Yangtze River Recent Developments/Updates
    2.11 Siyao
        2.11.1 Siyao Details
        2.11.2 Siyao Major Business
        2.11.3 Siyao Somatostatin Product and Services
        2.11.4 Siyao Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Siyao Recent Developments/Updates
    2.12 Shuangcheng
        2.12.1 Shuangcheng Details
        2.12.2 Shuangcheng Major Business
        2.12.3 Shuangcheng Somatostatin Product and Services
        2.12.4 Shuangcheng Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Shuangcheng Recent Developments/Updates
    2.13 Hainan Zhonghe
        2.13.1 Hainan Zhonghe Details
        2.13.2 Hainan Zhonghe Major Business
        2.13.3 Hainan Zhonghe Somatostatin Product and Services
        2.13.4 Hainan Zhonghe Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Hainan Zhonghe Recent Developments/Updates
    2.14 SL PHARM
        2.14.1 SL PHARM Details
        2.14.2 SL PHARM Major Business
        2.14.3 SL PHARM Somatostatin Product and Services
        2.14.4 SL PHARM Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 SL PHARM Recent Developments/Updates
    2.15 Wuhan Hualong
        2.15.1 Wuhan Hualong Details
        2.15.2 Wuhan Hualong Major Business
        2.15.3 Wuhan Hualong Somatostatin Product and Services
        2.15.4 Wuhan Hualong Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Wuhan Hualong Recent Developments/Updates
    2.16 Qingdao Guoda
        2.16.1 Qingdao Guoda Details
        2.16.2 Qingdao Guoda Major Business
        2.16.3 Qingdao Guoda Somatostatin Product and Services
        2.16.4 Qingdao Guoda Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Qingdao Guoda Recent Developments/Updates
    2.17 Chengdu Shengnuo
        2.17.1 Chengdu Shengnuo Details
        2.17.2 Chengdu Shengnuo Major Business
        2.17.3 Chengdu Shengnuo Somatostatin Product and Services
        2.17.4 Chengdu Shengnuo Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Chengdu Shengnuo Recent Developments/Updates
    2.18 Longjin
        2.18.1 Longjin Details
        2.18.2 Longjin Major Business
        2.18.3 Longjin Somatostatin Product and Services
        2.18.4 Longjin Somatostatin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Longjin Recent Developments/Updates

3 Competitive Environment: Somatostatin by Manufacturer
    3.1 Global Somatostatin Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Somatostatin Revenue by Manufacturer (2019-2024)
    3.3 Global Somatostatin Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Somatostatin by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Somatostatin Manufacturer Market Share in 2023
        3.4.2 Top 6 Somatostatin Manufacturer Market Share in 2023
    3.5 Somatostatin Market: Overall Company Footprint Analysis
        3.5.1 Somatostatin Market: Region Footprint
        3.5.2 Somatostatin Market: Company Product Type Footprint
        3.5.3 Somatostatin Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Somatostatin Market Size by Region
        4.1.1 Global Somatostatin Sales Quantity by Region (2019-2030)
        4.1.2 Global Somatostatin Consumption Value by Region (2019-2030)
        4.1.3 Global Somatostatin Average Price by Region (2019-2030)
    4.2 North America Somatostatin Consumption Value (2019-2030)
    4.3 Europe Somatostatin Consumption Value (2019-2030)
    4.4 Asia-Pacific Somatostatin Consumption Value (2019-2030)
    4.5 South America Somatostatin Consumption Value (2019-2030)
    4.6 Middle East and Africa Somatostatin Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Somatostatin Sales Quantity by Type (2019-2030)
    5.2 Global Somatostatin Consumption Value by Type (2019-2030)
    5.3 Global Somatostatin Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Somatostatin Sales Quantity by Application (2019-2030)
    6.2 Global Somatostatin Consumption Value by Application (2019-2030)
    6.3 Global Somatostatin Average Price by Application (2019-2030)

7 North America
    7.1 North America Somatostatin Sales Quantity by Type (2019-2030)
    7.2 North America Somatostatin Sales Quantity by Application (2019-2030)
    7.3 North America Somatostatin Market Size by Country
        7.3.1 North America Somatostatin Sales Quantity by Country (2019-2030)
        7.3.2 North America Somatostatin Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Somatostatin Sales Quantity by Type (2019-2030)
    8.2 Europe Somatostatin Sales Quantity by Application (2019-2030)
    8.3 Europe Somatostatin Market Size by Country
        8.3.1 Europe Somatostatin Sales Quantity by Country (2019-2030)
        8.3.2 Europe Somatostatin Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Somatostatin Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Somatostatin Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Somatostatin Market Size by Region
        9.3.1 Asia-Pacific Somatostatin Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Somatostatin Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Somatostatin Sales Quantity by Type (2019-2030)
    10.2 South America Somatostatin Sales Quantity by Application (2019-2030)
    10.3 South America Somatostatin Market Size by Country
        10.3.1 South America Somatostatin Sales Quantity by Country (2019-2030)
        10.3.2 South America Somatostatin Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Somatostatin Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Somatostatin Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Somatostatin Market Size by Country
        11.3.1 Middle East & Africa Somatostatin Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Somatostatin Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Somatostatin Market Drivers
    12.2 Somatostatin Market Restraints
    12.3 Somatostatin Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Somatostatin and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Somatostatin
    13.3 Somatostatin Production Process
    13.4 Somatostatin Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Somatostatin Typical Distributors
    14.3 Somatostatin Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Somatostatin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Somatostatin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Merck (Schweiz) AG Basic Information, Manufacturing Base and Competitors
    Table 4. Merck (Schweiz) AG Major Business
    Table 5. Merck (Schweiz) AG Somatostatin Product and Services
    Table 6. Merck (Schweiz) AG Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Merck (Schweiz) AG Recent Developments/Updates
    Table 8. SANOFI-AVENTIS FRANCE Basic Information, Manufacturing Base and Competitors
    Table 9. SANOFI-AVENTIS FRANCE Major Business
    Table 10. SANOFI-AVENTIS FRANCE Somatostatin Product and Services
    Table 11. SANOFI-AVENTIS FRANCE Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. SANOFI-AVENTIS FRANCE Recent Developments/Updates
    Table 13. Lyomark Pharma GmbH Basic Information, Manufacturing Base and Competitors
    Table 14. Lyomark Pharma GmbH Major Business
    Table 15. Lyomark Pharma GmbH Somatostatin Product and Services
    Table 16. Lyomark Pharma GmbH Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Lyomark Pharma GmbH Recent Developments/Updates
    Table 18. ALFA WASSERMANN S.p.A. Basic Information, Manufacturing Base and Competitors
    Table 19. ALFA WASSERMANN S.p.A. Major Business
    Table 20. ALFA WASSERMANN S.p.A. Somatostatin Product and Services
    Table 21. ALFA WASSERMANN S.p.A. Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. ALFA WASSERMANN S.p.A. Recent Developments/Updates
    Table 23. Polypeptide Laboratories, Inc Basic Information, Manufacturing Base and Competitors
    Table 24. Polypeptide Laboratories, Inc Major Business
    Table 25. Polypeptide Laboratories, Inc Somatostatin Product and Services
    Table 26. Polypeptide Laboratories, Inc Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Polypeptide Laboratories, Inc Recent Developments/Updates
    Table 28. SAMARTH Basic Information, Manufacturing Base and Competitors
    Table 29. SAMARTH Major Business
    Table 30. SAMARTH Somatostatin Product and Services
    Table 31. SAMARTH Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. SAMARTH Recent Developments/Updates
    Table 33. UBPL Basic Information, Manufacturing Base and Competitors
    Table 34. UBPL Major Business
    Table 35. UBPL Somatostatin Product and Services
    Table 36. UBPL Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. UBPL Recent Developments/Updates
    Table 38. HYBIO Basic Information, Manufacturing Base and Competitors
    Table 39. HYBIO Major Business
    Table 40. HYBIO Somatostatin Product and Services
    Table 41. HYBIO Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. HYBIO Recent Developments/Updates
    Table 43. TianTaiShan Basic Information, Manufacturing Base and Competitors
    Table 44. TianTaiShan Major Business
    Table 45. TianTaiShan Somatostatin Product and Services
    Table 46. TianTaiShan Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. TianTaiShan Recent Developments/Updates
    Table 48. Yangtze River Basic Information, Manufacturing Base and Competitors
    Table 49. Yangtze River Major Business
    Table 50. Yangtze River Somatostatin Product and Services
    Table 51. Yangtze River Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Yangtze River Recent Developments/Updates
    Table 53. Siyao Basic Information, Manufacturing Base and Competitors
    Table 54. Siyao Major Business
    Table 55. Siyao Somatostatin Product and Services
    Table 56. Siyao Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. Siyao Recent Developments/Updates
    Table 58. Shuangcheng Basic Information, Manufacturing Base and Competitors
    Table 59. Shuangcheng Major Business
    Table 60. Shuangcheng Somatostatin Product and Services
    Table 61. Shuangcheng Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. Shuangcheng Recent Developments/Updates
    Table 63. Hainan Zhonghe Basic Information, Manufacturing Base and Competitors
    Table 64. Hainan Zhonghe Major Business
    Table 65. Hainan Zhonghe Somatostatin Product and Services
    Table 66. Hainan Zhonghe Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Hainan Zhonghe Recent Developments/Updates
    Table 68. SL PHARM Basic Information, Manufacturing Base and Competitors
    Table 69. SL PHARM Major Business
    Table 70. SL PHARM Somatostatin Product and Services
    Table 71. SL PHARM Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. SL PHARM Recent Developments/Updates
    Table 73. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
    Table 74. Wuhan Hualong Major Business
    Table 75. Wuhan Hualong Somatostatin Product and Services
    Table 76. Wuhan Hualong Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Wuhan Hualong Recent Developments/Updates
    Table 78. Qingdao Guoda Basic Information, Manufacturing Base and Competitors
    Table 79. Qingdao Guoda Major Business
    Table 80. Qingdao Guoda Somatostatin Product and Services
    Table 81. Qingdao Guoda Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 82. Qingdao Guoda Recent Developments/Updates
    Table 83. Chengdu Shengnuo Basic Information, Manufacturing Base and Competitors
    Table 84. Chengdu Shengnuo Major Business
    Table 85. Chengdu Shengnuo Somatostatin Product and Services
    Table 86. Chengdu Shengnuo Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 87. Chengdu Shengnuo Recent Developments/Updates
    Table 88. Longjin Basic Information, Manufacturing Base and Competitors
    Table 89. Longjin Major Business
    Table 90. Longjin Somatostatin Product and Services
    Table 91. Longjin Somatostatin Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 92. Longjin Recent Developments/Updates
    Table 93. Global Somatostatin Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
    Table 94. Global Somatostatin Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 95. Global Somatostatin Average Price by Manufacturer (2019-2024) & (USD/Pcs)
    Table 96. Market Position of Manufacturers in Somatostatin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 97. Head Office and Somatostatin Production Site of Key Manufacturer
    Table 98. Somatostatin Market: Company Product Type Footprint
    Table 99. Somatostatin Market: Company Product Application Footprint
    Table 100. Somatostatin New Market Entrants and Barriers to Market Entry
    Table 101. Somatostatin Mergers, Acquisition, Agreements, and Collaborations
    Table 102. Global Somatostatin Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 103. Global Somatostatin Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 104. Global Somatostatin Consumption Value by Region (2019-2024) & (USD Million)
    Table 105. Global Somatostatin Consumption Value by Region (2025-2030) & (USD Million)
    Table 106. Global Somatostatin Average Price by Region (2019-2024) & (USD/Pcs)
    Table 107. Global Somatostatin Average Price by Region (2025-2030) & (USD/Pcs)
    Table 108. Global Somatostatin Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 109. Global Somatostatin Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 110. Global Somatostatin Consumption Value by Type (2019-2024) & (USD Million)
    Table 111. Global Somatostatin Consumption Value by Type (2025-2030) & (USD Million)
    Table 112. Global Somatostatin Average Price by Type (2019-2024) & (USD/Pcs)
    Table 113. Global Somatostatin Average Price by Type (2025-2030) & (USD/Pcs)
    Table 114. Global Somatostatin Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 115. Global Somatostatin Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 116. Global Somatostatin Consumption Value by Application (2019-2024) & (USD Million)
    Table 117. Global Somatostatin Consumption Value by Application (2025-2030) & (USD Million)
    Table 118. Global Somatostatin Average Price by Application (2019-2024) & (USD/Pcs)
    Table 119. Global Somatostatin Average Price by Application (2025-2030) & (USD/Pcs)
    Table 120. North America Somatostatin Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 121. North America Somatostatin Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 122. North America Somatostatin Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 123. North America Somatostatin Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 124. North America Somatostatin Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 125. North America Somatostatin Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 126. North America Somatostatin Consumption Value by Country (2019-2024) & (USD Million)
    Table 127. North America Somatostatin Consumption Value by Country (2025-2030) & (USD Million)
    Table 128. Europe Somatostatin Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 129. Europe Somatostatin Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 130. Europe Somatostatin Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 131. Europe Somatostatin Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 132. Europe Somatostatin Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 133. Europe Somatostatin Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 134. Europe Somatostatin Consumption Value by Country (2019-2024) & (USD Million)
    Table 135. Europe Somatostatin Consumption Value by Country (2025-2030) & (USD Million)
    Table 136. Asia-Pacific Somatostatin Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 137. Asia-Pacific Somatostatin Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 138. Asia-Pacific Somatostatin Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 139. Asia-Pacific Somatostatin Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 140. Asia-Pacific Somatostatin Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 141. Asia-Pacific Somatostatin Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 142. Asia-Pacific Somatostatin Consumption Value by Region (2019-2024) & (USD Million)
    Table 143. Asia-Pacific Somatostatin Consumption Value by Region (2025-2030) & (USD Million)
    Table 144. South America Somatostatin Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 145. South America Somatostatin Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 146. South America Somatostatin Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 147. South America Somatostatin Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 148. South America Somatostatin Sales Quantity by Country (2019-2024) & (K Pcs)
    Table 149. South America Somatostatin Sales Quantity by Country (2025-2030) & (K Pcs)
    Table 150. South America Somatostatin Consumption Value by Country (2019-2024) & (USD Million)
    Table 151. South America Somatostatin Consumption Value by Country (2025-2030) & (USD Million)
    Table 152. Middle East & Africa Somatostatin Sales Quantity by Type (2019-2024) & (K Pcs)
    Table 153. Middle East & Africa Somatostatin Sales Quantity by Type (2025-2030) & (K Pcs)
    Table 154. Middle East & Africa Somatostatin Sales Quantity by Application (2019-2024) & (K Pcs)
    Table 155. Middle East & Africa Somatostatin Sales Quantity by Application (2025-2030) & (K Pcs)
    Table 156. Middle East & Africa Somatostatin Sales Quantity by Region (2019-2024) & (K Pcs)
    Table 157. Middle East & Africa Somatostatin Sales Quantity by Region (2025-2030) & (K Pcs)
    Table 158. Middle East & Africa Somatostatin Consumption Value by Region (2019-2024) & (USD Million)
    Table 159. Middle East & Africa Somatostatin Consumption Value by Region (2025-2030) & (USD Million)
    Table 160. Somatostatin Raw Material
    Table 161. Key Manufacturers of Somatostatin Raw Materials
    Table 162. Somatostatin Typical Distributors
    Table 163. Somatostatin Typical Customers
List of Figures
    Figure 1. Somatostatin Picture
    Figure 2. Global Somatostatin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Somatostatin Consumption Value Market Share by Type in 2023
    Figure 4. 0.25mg/pcs Examples
    Figure 5. 0.75mg/pcs Examples
    Figure 6. 3mg/pcs Examples
    Figure 7. Global Somatostatin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 8. Global Somatostatin Consumption Value Market Share by Application in 2023
    Figure 9. Hormonal Disorder Examples
    Figure 10. Oncology Examples
    Figure 11. Metabolic Disorder Examples
    Figure 12. Others Examples
    Figure 13. Global Somatostatin Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Somatostatin Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Somatostatin Sales Quantity (2019-2030) & (K Pcs)
    Figure 16. Global Somatostatin Average Price (2019-2030) & (USD/Pcs)
    Figure 17. Global Somatostatin Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Somatostatin Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Somatostatin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Somatostatin Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Somatostatin Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Somatostatin Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Somatostatin Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Somatostatin Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Somatostatin Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Somatostatin Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Somatostatin Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Somatostatin Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Somatostatin Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Somatostatin Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Somatostatin Average Price by Type (2019-2030) & (USD/Pcs)
    Figure 32. Global Somatostatin Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Somatostatin Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Somatostatin Average Price by Application (2019-2030) & (USD/Pcs)
    Figure 35. North America Somatostatin Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Somatostatin Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Somatostatin Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Somatostatin Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Somatostatin Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Somatostatin Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Somatostatin Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Somatostatin Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Somatostatin Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Somatostatin Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Somatostatin Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Somatostatin Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Somatostatin Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Somatostatin Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Somatostatin Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Somatostatin Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Somatostatin Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Somatostatin Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Somatostatin Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Somatostatin Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Somatostatin Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Somatostatin Market Drivers
    Figure 76. Somatostatin Market Restraints
    Figure 77. Somatostatin Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Somatostatin in 2023
    Figure 80. Manufacturing Process Analysis of Somatostatin
    Figure 81. Somatostatin Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin

Related Reports

Global Somatostatin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Somatostatin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Global Somatostatin Supply, Demand and Key Producers, 2024-2030

Global Somatostatin Supply, Demand and Key Producers, 2024-2030

date 20 Feb 2024

date Pharma & Healthcare

The global Somatostatin market size is expected to reach $ 715 million by 2030, rising at a market growth of 10.9% CAGR during the forecast period (2024-2030).

Product Tags

Somatostatin and Somatostatin Analogs

Somatostatin

Somatostatin Analogue Drug

Somatostatin Receptor Type 4

Somatostatin Receptor Type 2

Somatostatin Drugs

Somatostatin Acetate

Somatostatin for Injection

Somatostatin Analogs

Somatostatin API

Long-acting Somatostatin Analogues (LA SSAs)

Manmade Version of Somatostatin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>